Cailin Conner

DocwireNews

One of the most common forms of inflammatory arthritis is gout, and it carries a degree of disease burden. Gout is a result of uric acid deposition between the joints, and caused symptoms such as intense joint pain, lingering discomfort, limited range of motion, and inflammation and redness. Gout is often associated with comorbidities such as diabetes, chronic kidney disease, and cardiovascular disease. Previous <a href="https://rmdopen.bmj.com/content/4/2/e000712" target="_blank" rel="noopener">studies</a> have found the prevalence of atrial fibrillation (AF) and cardiovascular mortality is higher in patients with gout than in those without.A risk factor for gout is increased age, and with increased age comes increased risks for infections such as influenza. A <a href="https://www.heartrhythmjournal.com/article/S1547-5271(16)00126-0/fulltext" target="_blank" rel="noopener">study</a> by Rondy et al. found that influenza infection was significantly associated with the development of AF, which could be reduced through influenza vaccination.Published in <a href="https://www.frontiersin.org/articles/10.3389/fphar.2022.990713/full#B35" target="_blank" rel="noopener">Frontiers in Pharmacology</a>, researchers evaluated the protective effect of influenza vaccination against AF in patients with gout. Utilizing a national database, more than 25,000 patients with gout aged &gt;55 years were retrospectively reviewed. Patients were divided into vaccinated (n = 13,201) and unvaccinated cohorts (n = 13,042). Researchers evaluated patients&rsquo; medications, sociodemographic information, and the risk of AF.In all seasons (both influenza and noninfluenza seasons), the risk of AF was significantly lower in vaccinated patients than in unvaccinated patients. There were no significant differences observed between female and male sex and the risk of AF after vaccination. &ldquo;We also observed a significantly decreased risk of AF among patients aged 55&ndash;64, 65&ndash;74, and &ge;75 years during all seasons,&rdquo; the authors noted. After main model analysis, there was a significantly decreased risk of AF in patients with the administration of more vaccine doses. Additionally, compared with unvaccinated patients, those who were vaccinated demonstrated increased long-term use (&ge;28 days) of gout medications.As the mechanism of AF risk reduction, the authors said, &ldquo;In patients with influenza, inflammatory cytokines are produced, and the sympathetic nervous system is activated. Infection with influenza may also cause myocarditis, which leads to AF by affecting the electrical system of the heart. Therefore, influenza vaccination can prevent AF by reducing the aforementioned risks during an infection with influenza.&rdquo;The authors stated that, while the influenza vaccination is associated with a decreased risk of AF in patients with gout, further analysis is needed to validate their findings.

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

Rob Dillard

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Latest News

Influenza Vaccination Is Associated With Lower Risk of AF in Gout Patients

Nephrology Times

One of the most common forms of inflammatory arthritis is gout, and it carries a degree of disease burden. Gout is a result of uric acid deposition between the joints, and ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe